Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exercise

BACKGROUND: To investigate the long-term economic outcome of dapagliflozin versus metformin in Chinese patients with type 2 diabetes mellitus (T2DM) whose diet and exercise have not provided sufficient glycemic control. METHODS: An economic analysis of dapagliflozin versus metformin was conducted by...

Descripción completa

Detalles Bibliográficos
Autores principales: Nian, Hua, Wan, Xu, Ma, Jing, Jie, Fu, Wu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048053/
https://www.ncbi.nlm.nih.gov/pubmed/32140079
http://dx.doi.org/10.1186/s12962-020-00208-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048053/
https://www.ncbi.nlm.nih.gov/pubmed/32140079
http://dx.doi.org/10.1186/s12962-020-00208-w

Ejemplares similares